Levin Capital Strategies’s Pulse Biosciences PLSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-19,939
Closed -$80.4K 295
2023
Q3
$80.4K Hold
19,939
0.01% 245
2023
Q2
$143K Hold
19,939
0.02% 230
2023
Q1
$67K Hold
19,939
0.01% 225
2022
Q4
$55.2K Hold
19,939
0.01% 228
2022
Q3
$46K Hold
19,939
0.01% 221
2022
Q2
$31K Hold
19,939
﹤0.01% 253
2022
Q1
$97K Hold
19,939
0.01% 281
2021
Q4
$295K Hold
19,939
0.03% 230
2021
Q3
$431K Hold
19,939
0.04% 188
2021
Q2
$327K Hold
19,939
0.03% 216
2021
Q1
$472K Buy
19,939
+578
+3% +$17.3K 0.05% 154
2020
Q4
$462K Hold
19,361
0.05% 157
2020
Q3
$228K Buy
19,361
+361
+2% +$3.88K 0.03% 215
2020
Q2
$199K Buy
19,000
+4,000
+27% +$36K 0.03% 163
2020
Q1
$107K Hold
15,000
0.02% 156
2019
Q4
$201K Hold
15,000
0.02% 183
2019
Q3
$232K Hold
15,000
0.03% 164
2019
Q2
$198K Hold
15,000
0.02% 184
2019
Q1
$264K Hold
15,000
0.03% 153
2018
Q4
$172K Hold
15,000
﹤0.01% 224
2018
Q3
$213K Hold
15,000
﹤0.01% 240
2018
Q2
$227K Hold
15,000
﹤0.01% 245
2018
Q1
$203K Hold
15,000
﹤0.01% 275
2017
Q4
$354K Hold
15,000
0.01% 222
2017
Q3
$279K Buy
+15,000
New +$341K ﹤0.01% 266
2017
Q2
Sell
-10,000
Closed -$204K 330
2017
Q1
$204K Buy
+10,000
New +$136K ﹤0.01% 273

Other funds holding PLSE

Levin Capital Strategies's PLSE Position: Q4 2023 in Review

Levin Capital Strategies sold out of Pulse Biosciences (PLSE) in Q4 2023, closing a stake of 19,939 shares — an estimated $80.4K sold.

Levin Capital Strategies first reported a position in PLSE in Q1 2017 and held it in 26 quarters. The position peaked at $472K in Q1 2021. 50 funds tracked by Wall St. Rank hold PLSE as of Q4 2023.

  • Levin Capital Strategies reported no remaining Pulse Biosciences position as of Q4 2023 after selling out during the quarter.
  • Levin Capital Strategies sold 19,939 Pulse Biosciences shares in Q4 2023, an estimated $80.4K.
  • Levin Capital Strategies first reported a position in Pulse Biosciences in Q1 2017 and held it in 26 quarters.
  • Levin Capital Strategies's Pulse Biosciences position peaked at $472K in Q1 2021.
  • 50 funds tracked by Wall St. Rank held Pulse Biosciences as of Q4 2023.

Based on Levin Capital Strategies's 13F filing for Q4 2023, filed 6 Feb 2024.